Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current

News

Nevro Q1 2024 GAAP EPS $(0.70) Beats $(1.08) Estimate, Sales $101.899M Beat $97.892M Estimate

Author: Benzinga Newsdesk | May 07, 2024 04:59pm
Nevro (NYSE:NVRO) reported quarterly losses of $(0.70) per share which beat the analyst consensus estimate of $(1.08) by 35.19 percent. This is a 28.57 percent increase over losses of $(0.98) per share from the same period last year. The company reported quarterly sales of $101.899 million which beat the analyst consensus estimate of $97.892 million by 4.09 percent. This is a 5.78 percent increase over sales of $96.327 million the same period last year.

Posted In: NVRO